The report and analysis concerning the usefulness of basic telemedicine tools in the skin cancer diagnostic screening process during COVID-19 pandemics.

COVID-19 melanoma screening programme teledermatology telemedical consultation

Journal

Postepy dermatologii i alergologii
ISSN: 1642-395X
Titre abrégé: Postepy Dermatol Alergol
Pays: Poland
ID NLM: 101168357

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 23 11 2020
accepted: 29 01 2021
entrez: 4 4 2022
pubmed: 5 4 2022
medline: 5 4 2022
Statut: ppublish

Résumé

A rapid spread of the emerging COVID-19 pandemic limited the availability of professional medical advice. As a result, a significant increase in the number of undiagnosed and chronically ill patients without medical care was noticed. In reaction to the urgent need, the telemedical consultation, instead of the classical form, may be introduced as a vulnerable tool in preclinical evaluation of patients with potentially malignant skin lesions. In this study the results of the implementation of telemedical consultation programme with the intention to early detect the skin cancers in patients who, due to the COVID-19 pandemic, could not undergo the standard consultation was presented. The programme of remote dermatological consultation, which was introduced on 1 June 2020, covered all patients who had no possibility or will to visit the standard healthcare units. In case of suspicion of life-threatening skin lesions patients were invited for additional diagnostics or surgery. Obtained data, including demography, age, surgery description and pathomorphological examination were descriptively analysed. In total, 80 consecutive patients were enrolled during the screening programme. In total, 31 lesions in 25 patients were excised. In this group there were 10 serious diagnoses including 5 cases of basal cell carcinoma, melanoma in situ and dysplastic nevi. Moreover, another 10 patients were referred to other specialists or specific recommendations were advised. An alternative track using teledermatology for patients with skin diseases was successfully introduced under the specific conditions of epidemiologic danger. Despite its disadvantages teledermatology enabled the diagnosis and treatment in a significant number of serious cases.

Identifiants

pubmed: 35369642
doi: 10.5114/ada.2022.113605
pii: 46425
pmc: PMC8953878
doi:

Types de publication

Journal Article

Langues

eng

Pagination

189-194

Informations de copyright

Copyright © 2022 Termedia.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Br J Dermatol. 2007 Mar;156(3):412-9
pubmed: 17300227
Intern Emerg Med. 2020 Aug;15(5):787-790
pubmed: 32519136
In Vivo. 2020 Jun;34(3 Suppl):1651-1659
pubmed: 32503825
Int J Surg. 2020 Jun;78:185-193
pubmed: 32305533
Lancet Child Adolesc Health. 2020 May;4(5):e10-e11
pubmed: 32278365
Br J Dermatol. 2011 Nov;165(5):1058-65
pubmed: 21729026
J Eur Acad Dermatol Venereol. 2014 Aug;28(8):1103-8
pubmed: 24372877
Comput Med Imaging Graph. 2007 Sep;31(6):362-73
pubmed: 17387001
Public Health. 2020 Jun;183:40-41
pubmed: 32417567
MMWR Morb Mortal Wkly Rep. 2020 Sep 11;69(36):1250-1257
pubmed: 32915166
J Health Serv Res Policy. 2011 Apr;16(2):108-17
pubmed: 20819913
Ann R Coll Surg Engl. 2020 May;102(5):323-332
pubmed: 32352836
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):965-967
pubmed: 32604016
Cochrane Database Syst Rev. 2018 Dec 04;12:CD013192
pubmed: 30521685
Dermatol Ther. 2020 Jul;33(4):e13495
pubmed: 32458588
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):1136-1139
pubmed: 32333832
Postepy Dermatol Alergol. 2020 Apr;37(2):159-167
pubmed: 32489348
J Med Syst. 2020 Jun 15;44(7):132
pubmed: 32542571
Clin Rheumatol. 2020 Jul;39(7):2043-2047
pubmed: 32514674
Adv Clin Exp Med. 2020 Sep;29(9):1021-1028
pubmed: 33001589
J Am Med Inform Assoc. 2020 Jul 1;27(7):1132-1135
pubmed: 32324855
N Engl J Med. 2020 Dec 17;383(25):2427-2438
pubmed: 32991794
Dermatology. 2019;235(1):11-18
pubmed: 30404085
Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):2006-2011
pubmed: 32141569
J Med Internet Res. 2020 Aug 7;22(8):e19493
pubmed: 32721925

Auteurs

Marcin Ziętek (M)

Wroclaw Comprehensive Cancer Center, Wroclaw, Poland.
Department of Oncology, Wroclaw Medical University, Wroclaw, Poland.

Maciej Nowacki (M)

Wroclaw Comprehensive Cancer Center, Wroclaw, Poland.
Chair of Surgical Oncology, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland.

Jędrzej Wierzbicki (J)

SSG Group, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland.

Rafał Matkowski (R)

Wroclaw Comprehensive Cancer Center, Wroclaw, Poland.
Department of Oncology, Wroclaw Medical University, Wroclaw, Poland.

Adam Maciejczyk (A)

Wroclaw Comprehensive Cancer Center, Wroclaw, Poland.
Department of Oncology, Wroclaw Medical University, Wroclaw, Poland.

Rafał Czajkowski (R)

Department of Dermatology and Venereology, Faculty of Medicine, Ludwik Rydygier Medical College in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland.

Edyta Pawlak-Adamska (E)

Department of Experimental Therapy, Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.

Classifications MeSH